IGF1 and myopathy: Skeletal muscle abnormalities including widespread myopathy phenotype with atrophy, decreased insulin-like growth factor-1 (IGF-1) signaling, increased oxidative stress, and impaired functionality have been observed in experimental and clinical studies [8,9,10,11,12,13,14,15].